Comparing The Effects Of Endogenous And Synthetic Cannabinoid Receptor Agonists On Survival Of Gastric Cancer Cells

Cancer (Gastric)

Key Findings

The three agents tested exhibited similar concentration-dependent effects in the induction of changes in cell morphology and cell loss, as well as in the decrease of cell viability and DNA laddering in the human gastric adenocarcinoma cell line (AGS). Our results support and confirm the therapeutic potential that cannabinoid receptor agonists exert in gastric cancer cells and open possibilities to use cannabinoids as part of a new gastric cancer therapy.

Information and Links


Link: Comparing The Effects Of Endogenous And Synthetic Cannabinoid Receptor Agonists On Survival Of Gastric Cancer Cells

Year: 2016

DOI: 10.1016/j.lfs.2016.09.010


Ratings

(How Ratings Work)

Cancer (Gastric) — 1


Possibility of efficacy for cannabis in treatment of Cancer (Gastric) according to the results found in this study.

Drugs Used

Anandamide (AEA), (R)-(+)-methanandamide (Meth-AEA) and CP 55,940